CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding

Phase 1POP BIO SNAP™Positive
AI Analysis

Summary

POP Biotechnologies secured up to $9.7 million in CEPI funding to advance its POP BIO SNAP™ nanoparticle vaccine platform into Phase 1 clinical trials in the U.S.

Clinical Trial Data

Phase

Phase 1

Importance:6/10
Sentiment:
0.70
fundingvaccine platformnanoparticlePhase 1clinical trials

Read the original article

Published by GlobeNewswire Clinical Studies on June 3, 2026 11:25 PM

Read Original